TP53 and neoplasm: The clock genes exert genetic and epigenetic regulatory effects that facilitate the circadian expression of ~5–10% of the entire mammalian transcriptome (6–10), including other known tumor suppressors and oncogenes (e.g., c-Myc, p53) (31,61,62).